FDA Withdraws Approval of New Drug and Abbreviated New Drug Applications from Pharmacia & Upjohn et al.

Summary

The US Food and Drug Administration (FDA) has withdrawn approval of one new drug application (NDA) and four abbreviated new drug applications (ANDAs) submitted by Pharmacia & Upjohn et al. following notification from the applicants that the drug products are no longer commercially available.